These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33276675)

  • 1. Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents.
    Spina E; Barbieri MA; Cicala G; de Leon J
    Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33276675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentially Clinically Relevant Pharmacodynamic Interactions Between Antiepileptic Drugs and Psychotropic Drugs: An Update.
    Spina E; Leon J
    Curr Pharm Des; 2017; 23(37):5625-5638. PubMed ID: 28799514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics.
    Spina E; Pisani F; de Leon J
    Pharmacol Res; 2016 Apr; 106():72-86. PubMed ID: 26896788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
    Hahn J; Choi JH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
    Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
    Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of pharmacokinetic and pharmacodynamic interactions with antipsychotics.
    Wijesinghe R
    Ment Health Clin; 2016 Jan; 6(1):21-27. PubMed ID: 29955443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically relevant interactions between newer antidepressants and second-generation antipsychotics.
    Spina E; de Leon J
    Expert Opin Drug Metab Toxicol; 2014 May; 10(5):721-46. PubMed ID: 24494611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between antiepileptics and second-generation antipsychotics.
    de Leon J; Santoro V; D'Arrigo C; Spina E
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):311-34. PubMed ID: 22332980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching atypical antipsychotics: a review.
    Chue P; Stip E; Remington G; Kopala L
    Acta Neuropsychiatr; 2004 Dec; 16(6):301-13. PubMed ID: 26984543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants.
    Italiano D; Spina E; de Leon J
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1457-89. PubMed ID: 25196459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinically relevant drug interactions with new generation antidepressants and antipsychotics].
    Eckert A
    Ther Umsch; 2009 Jun; 66(6):485-92. PubMed ID: 19496045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics for the treatment of delirious elders.
    Ozbolt LB; Paniagua MA; Kaiser RM
    J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypicality of atypical antipsychotics.
    Farah A
    Prim Care Companion J Clin Psychiatry; 2005; 7(6):268-74. PubMed ID: 16498489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically important differences in the pharmacokinetics of the ten newer "atypical" antipsychotics: part 1.
    Preskorn SH
    J Psychiatr Pract; 2012 May; 18(3):199-204. PubMed ID: 22617084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer antipsychotics: comparative review of drug interactions.
    Spina E; Scordo MG
    Expert Rev Neurother; 2001 Nov; 1(2):171-82. PubMed ID: 19811029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics and glucose homeostasis.
    Bergman RN; Ader M
    J Clin Psychiatry; 2005 Apr; 66(4):504-14. PubMed ID: 15816794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.
    Onufrak NJ; Forrest A; Gonzalez D
    Clin Ther; 2016 Sep; 38(9):1930-47. PubMed ID: 27449411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically important differences in the pharmacokinetics of the ten newer "atypical" antipsychotics: Part 2. Metabolism and elimination.
    Preskorn SH
    J Psychiatr Pract; 2012 Sep; 18(5):361-8. PubMed ID: 22995963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A typical mood stabilizers: a "typical role for atypical antipsychotics.
    Malhi GS; Berk M; Bourin M; Ivanovski B; Dodd S; Lagopoulos J; Mitchell PB
    Acta Psychiatr Scand Suppl; 2005; (426):29-38. PubMed ID: 16104066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.